A pan-immunotherapy signature to predict intratumoral CD8+ T cell expansions [scTCR_immunotherapies]
Single-cell RNA-seq · mouse · 91 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Samples
- 91 samples: 91 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE304763_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1302469 and SRA study SRP607072. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 91 sample titles: 91 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9156520 ExT29_day14_Tumor_DP_LAG3_1 (bulk TCR)
- GSM9156521 ExT29_day14_Tumor_DP_LAG3_3 (bulk TCR)
- GSM9156522 ExT29_day14_Tumor_DP_LAG3_4 (bulk TCR)
- GSM9156523 ExT29_day14_Tumor_DP_LAG3_6 (bulk TCR)
- GSM9156524 ExT29_day14_Tumor_DP_LAG3_7 (bulk TCR)
- GSM9156525 ExT29_day14_Tumor_DP_PDL1CTLA4_2 (bulk TCR)
- GSM9156526 ExT29_day14_Tumor_DP_PDL1CTLA4_5 (bulk TCR)
- GSM9156527 ExT29_day14_Tumor_DP_PDL1CTLA4_8 (bulk TCR)
- GSM9156528 ExT29_day14_Tumor_DP_PDL1CTLA4_9 (bulk TCR)
- GSM9156529 ExT29_day14_Tumor_DP_PDL1CTLA4_10 (bulk TCR)
- GSM9156530 ExT29_day14_Tumor_DP_PDL1CTLA4_11 (bulk TCR)
- GSM9156531 ExT29_day14_Tumor_Ly108_LAG3_1 (bulk TCR)
- GSM9156532 ExT29_day14_Tumor_Ly108_LAG3_3 (bulk TCR)
- GSM9156533 ExT29_day14_Tumor_Ly108_LAG3_4 (bulk TCR)
- GSM9156534 ExT29_day14_Tumor_Ly108_LAG3_6 (bulk TCR)
- GSM9156535 ExT29_day14_Tumor_Ly108_LAG3_7 (bulk TCR)
- GSM9156536 ExT29_day14_Tumor_Ly108_PDL1CTLA4_2 (bulk TCR)
- GSM9156537 ExT29_day14_Tumor_Ly108_PDL1CTLA4_5 (bulk TCR)
- GSM9156538 ExT29_day14_Tumor_Ly108_PDL1CTLA4_8 (bulk TCR)
- GSM9156539 ExT29_day14_Tumor_Ly108_PDL1CTLA4_9 (bulk TCR)
- GSM9156540 ExT29_day14_Tumor_Ly108_PDL1CTLA4_10 (bulk TCR)
- GSM9156541 ExT29_day14_Tumor_Ly108_PDL1CTLA4_11 (bulk TCR)
- GSM9156542 ExT29_day14_Tumor_PD1nega_LAG3_1 (bulk TCR)
- GSM9156543 ExT29_day14_Tumor_PD1nega_LAG3_3 (bulk TCR)
- GSM9156544 ExT29_day14_Tumor_PD1nega_LAG3_4 (bulk TCR)
- GSM9156545 ExT29_day14_Tumor_PD1nega_LAG3_6 (bulk TCR)
- GSM9156546 ExT29_day14_Tumor_PD1nega_LAG3_7 (bulk TCR)
- GSM9156547 ExT29_day14_Tumor_PD1nega_PDL1CTLA4_2 (bulk TCR)
- GSM9156548 ExT29_day14_Tumor_PD1nega_PDL1CTLA4_5 (bulk TCR)
- GSM9156549 ExT29_day14_Tumor_PD1nega_PDL1CTLA4_8 (bulk TCR)
- GSM9156550 ExT29_day14_Tumor_PD1nega_PDL1CTLA4_9 (bulk TCR)
- GSM9156551 ExT29_day14_Tumor_PD1nega_PDL1CTLA4_10 (bulk TCR)
- GSM9156552 ExT29_day14_Tumor_PD1nega_PDL1CTLA4_11 (bulk TCR)
- GSM9156553 ExT29_day14_Tumor_Tim3_LAG3_1 (bulk TCR)
- GSM9156554 ExT29_day14_Tumor_Tim3_LAG3_3 (bulk TCR)
- GSM9156555 ExT29_day14_Tumor_Tim3_LAG3_4 (bulk TCR)
- GSM9156556 ExT29_day14_Tumor_Tim3_LAG3_6 (bulk TCR)
- GSM9156557 ExT29_day14_Tumor_Tim3_LAG3_7 (bulk TCR)
- GSM9156558 ExT29_day14_Tumor_Tim3_PDL1CTLA4_2 (bulk TCR)
- GSM9156559 ExT29_day14_Tumor_Tim3_PDL1CTLA4_5 (bulk TCR)
+ 51 more — browse all 91 samples with per-sample file links →
- GSE337601 XCR1+ and CD11b+ migratory dendritic cells cooperate for the crosspriming of intratumoral CD8+ T cells with a tissue-resident memory phenotype [RNA-Seq] 36 samples shares cd8, intratumoral
- GSE261642 PLPP1-deficiency-mediated ferroptosis induced by PD-1 signaling impairs antitumor activity of intratumoral CD8+ T cells I 23 samples shares cd8, intratumoral
- GSE281719 PD-1 Mediated Regulation of Unique Activated CD8+ T Cells by NK Cells in the Submandibular Gland [I15, I16] 60 samples shares cd8
- GSE334890 Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors 48 samples shares cd8
- GSE215762 Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells 41 samples shares cd8
- GSE270050 Expansion of Tumor-Infiltrating CD8+ T Cell Clonotypes Occurs in the Spleen in Response to Immune Checkpoint Blockade 29 samples shares cd8
- GSE317032 Non-cytolytic viral vaccine vectors induce durable effector-memory CD8 T cell immunity by triggering type I interferon 18 samples shares cd8
- GSE286266 Age influences CMV-specific NK and CD8 T cell memory fates (NK cells) 12 samples shares cd8
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.